The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
about
Somatic mutations in early onset luminal breast cancer.Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer ProgressionSmurfs in Protein Homeostasis, Signaling, and Cancer
P2860
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@ast
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@en
type
label
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@ast
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@en
prefLabel
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@ast
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@en
P2093
P2860
P356
P1433
P1476
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
@en
P2093
Amrita Singh Chandhoke
Ayan Chanda
Kunal Karve
Shirin Bonni
P2860
P304
21001-21014
P356
10.18632/ONCOTARGET.15471
P407
P577
2017-03-01T00:00:00Z